FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely neurology, and concerns treating kinetosis. That is ensured by administering an activated potentiated form of anti-brain specific protein S-100 antibodies in a combination with an activated potentiated form of anti-endothelial NO-synthase antibodies.
EFFECT: combined administration provides the effective treatment of kinetosis ensured by synergetic action of the administered medicinal agents.
10 cl, 9 tbl, 2 ex
